|
| |
Martek BiosciencesMartek Biosciences Corporation is a leader in the development and commercialization of high value products derived frommicroalgae. Martek's leading products are nutritional oils used as ingredients in infant formula and encapsulated for use as dietary supplements. The Company's nutritional oils are comprised of fatty acid components which many researchers believe may enhance mental and visual development in infants and play a pivotal role in brain function throughout life. Martek has licensed these oils to six infant formula manufacturers, representing over 40% of the estimated $5 billion worldwide market for infant formula. Four of these licensees are marketing term infant formula products containing Martek's oils
in seven countries and pre-term infant formula products containing the Company's oils in 50 countries. Additional applications of the Company's platform technology include currently marketed products and technologies to assist in drug discovery and diagnostics. Martek intends to continue to exploit the largely untapped commercial opportunities of microalgae. To that end, the Company maintains a library of more than 3,000 live microalgal species and a related database, which it believes are among the largest such resources available worldwide.
| Contact Details: |
| 6480 Dobbin Road |
| Columbia |
| MD |
| 21045 |
| United States of America |
| Tel: | 410 740 0081 |
| Fax: | 410 740 2985 |
| Email: | pat@martekbio.com |
| WWW: | www.martekbio.com/
|
|
Loading...
|
Recent Publications by Martek Biosciences: |  |
The hypolipidemic effect of an ethyl ester of algal-docosahexaenoic acid in rats fed a high-fructose diet.
Preclinical and clinical studies demonstrate that the omega-3 fatty acids... | 18th November, 2009
| Martek Biosciences Corporation, 6480 Dobbin Road, Columbia, MD 21045, USA.
| Lipids. 2009 Sep;44(9):817-26. Epub 2009 Aug 5.
DOI Direct Link |
Biochemical characterization of polyunsaturated fatty acid synthesis in Schizochytrium: release of the products as free fatty acids.
In marine bacteria and some thraustochytrids (marine stramenopiles)... | 22nd October, 2009
| Martek Biosciences Boulder Corporation, Boulder, CO 80301, USA.
| Plant Physiol Biochem. 2009 Jun;47(6):472-8. Epub 2009 Feb 15.
DOI Direct Link |
Characterization of both polyunsaturated fatty acid biosynthetic pathways in Schizochytrium sp.
Schizochytrium produces long chain polyunsaturated fatty acids (PUFAs) via... | 1st October, 2009
| Martek Biosciences Corporation, 6480 Dobbin Rd, Columbia, MD 21045-5825,
| Lipids. 2009 Jul;44(7):621-30. Epub 2009 Jun 3.
DOI Direct Link |
Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6).
17S-HDPAn-6 (17S-hydroxydocosa-4Z,7Z,10Z,13Z,15E-pentaenoic acid) and... | 15th August, 2009
| Martek Biosciences Corp., 6480 Dobbin Road, Columbia, MD 21045, USA.
| Biochem Pharmacol. 2010 Jan 15;79(2):251-60. Epub 2009 Aug 11.
DOI Direct Link |
Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6).
Enzymatically oxygenated derivatives of the omega-3 fatty acids... | 30th June, 2009
| Martek Biosciences Corporation, Columbia, Maryland 21045, USA.
| J Biol Chem. 2009 May 29;284(22):14744-59. Epub 2009 Mar 26.
DOI Direct Link |
→View more Martek Biosciences research publications. |
Press Releases on Martek Biosciences:
|
 |
| Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report |
22nd September, 2009 |
Reportlinker |
-- Zymes LLC
Benefits of this Report
This report provides a valuable, timely and comprehensive exploration of the omega-enhanced food and beverage market aimed at companies already
|
| Martek to Present at Two Upcoming Investor Conferences |
15th September, 2009 |
Martek Biosciences Corporation |
COLUMBIA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be participating in two upcoming investor conferences. On Monday,
|
| Alzheimer's Drug Discovery Foundation Hosts 10th International Conference on Alzheimer's Drug Discovery - September 14-15 |
1st September, 2009 |
Alzheimer's Drug Discovery Foundation |
Latest Trends and Research Released on Alzheimer's Disease by Academic and Biotech Industry Scientists
NEW YORK, Sept. 1 /PRNewswire-USNewswire/ -- The 10th International Conference on Alzheimer&
|
| BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels |
11th August, 2009 |
Martek Biosciences Corporation |
-- Reduced exposure to vegetable oil price.
Martek
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the development and production of high-value oils from algae and other microbial
|
| Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline |
12th July, 2009 |
Alzheimer's Association |
-- Karin Yurko-Mauro, et al - Results of the MIDAS Trial: Effects of
Docosahexaenoic Acid on Physiological and Safety Parameters in
Age-Related Cognitive Decline (Funder: Martek
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 648 times since April 2007, the link to the organisation's website has been followed 94 times Recent Search Terms used to find this page: martek boulder co | martek lipids | publications by martek | martek direct | martek biosciences usa | martek pdf | martek pdf | Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer s Disease in Vienna, Austria. promote | tgf beta in infant formula | martek patents | . Search for more companies in Columbia Search for more companies in MD This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Martek Biosciences |
